Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Офтальмология / Английские материалы / Pediatric Clinical Ophthalmology A Color Handbook_Olitsky, Nelson_2012.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
16.75 Mб
Скачать

 

 

Index

313

 

Note: Page numbers in italic

angle kappa 29

astrocytoma

refer to tables or boxes

angle surgery 120, 128,

optic nerve 224

 

129

paraventricular 220, 221

acetazolamide 128

anhidrosis 240

pilocytic 224, 272, 273

acetylcholine receptors 242

aniridia 106, 124

atopic keratoconjunctivitis

achromatopsia 138–9

anisometropia 32, 44, 48,

(AKC) 78, 79

aciclovir 76

108

atropine 49

acoustic neuroma 222

ankyloblepharon 186

attention deficit hyperactivity

adenoma sebaceum 220

annulus of Zinn 14

disorder (ADHD) 214

adhesions 123, 125

anomalous head positions

aura, migraine 237

adrenergic agonists 128

(AHPs) 214

autorefraction 32

AIDS 248, 272

anophthalmia 186

Axenfeld–Rieger syndrome

Alagille’s syndrome 106

anterior chamber 18

106, 123

albinism 148–9, 210–15

hemorrhage (hyphema)

azithromycin 72

Allen figures 24

126, 157, 282–3

β-hemolytic streptococci 70

allergens 79

maldevelopment 119

Allgrove syndrome 183

anterior segment

bacitracin 72

Alport syndrome 104, 105

anatomy 17–19, 66, 67

bacterial conjunctivitis 69–73

amacrine cells 19

dysgenesis syndromes 106

balloon dacryoplasty 181

amblyopia

embryogenesis 86

band keratopathy 156

ametropic 44

anterior segment

Bardet–Biedl syndrome

anisometropic 44

(iridocorneal) angle 18

149–50

cataracts 108, 111

anterior uveitis 126, 155–7,

basal cell carcinoma 248

classification 44

155

basal cell nevus syndrome 190

congenital rubella 216

antibiotic resistance 72, 73

Best’s disease 142–3

diagnosis 27, 47–8

antibiotic/steroid

beta blockers, topical 128

etiology and epidemiology

combinations 72, 82

bevacizumab 42

43–5

antihistamines, and tear

bimatoprost 128

in glaucoma 116, 120

production 183

birth trauma 88–9, 117

management 48–9

antioxidant therapy 41–2

birth weight, and ROP 34,

organic 45

aphakia 98, 110, 111

38

in ptosis 187

apraclonidine 128

bisphosphonates 202

strabismic 44

arginine 150

black sunburst 209

visual deprivation 45

Ascaris lumbricoides 82

blepharitis 183, 189–90

American Academy of

ash leaf sign 220, 221

blepharoptosis 187–8, 248,

Pediatrics (AAP) 31

Ashkenazi Jewish populations

249

aminoglycosides 72

94

blepharospasm 116, 189

Ancyclostoma duodenale 82

asthma 80

blindness, healthcare priority

aneurysm, intracranial 58

astigmatism, corneal dermoid

33

angiofibroma 220, 221

88, 89

BLOCK-ROP Trial 42

angiotensin-converting

astrocytic hamartoma, retinal

blow-out fracture 286, 287

enzyme (ACE) 156

218–20, 266, 267

blue nevus 248

314 Index

 

 

 

blue-cone monochromatism

chlamydial infections 74,

conjunctivitis 68–9

138

83–4, 83

algorithm for differential

Brazil 259

chloramphenicol 72

diagnosis 68

brimonidine 128

‘chloroma’ (granulocytic

allergic 78–9, 192

brinzolamide 128

sarcoma) 272

bacterial 69–73

Brown’s syndrome 62

‘chocolate cysts’ 257

giant papillary 77

Bruch’s membrane 20, 209

choriocapillaris 20

hemorrhagic 74, 75

Bruckner Test 23, 24, 25, 108

choristomas 249–52, 250

herpes 76

Burkitt’s lymphoma 272

complex 252

types 69

 

epibulbar complex 233

viral 74–5

café au lait spots 122, 224,

lacrimal gland 252

conjunctivitis–otitis media

225

choroid 152

syndrome 71

canalicular system 178

choroidal freckles/nevi 222,

Conradi syndrome 105

injury 276, 277

223, 268, 269

contact lens

Candida albicans 82

choroidal hemangioma

astigmatism 89

carbonic anhydrase inhibitors

230–1, 266

conjunctivitis 70, 71, 77

128

choroidal osteoma 266, 267

corneal abrasion 280

cataracts 100–3

ciliary body 18–19, 152

position on globe 66

anterior polar 100, 101

medulloepithelioma 266,

copper transport, disorder

cerulean (blue-dot) 102

267

200

‘Christmas tree’ 105

ciliary flush 126, 152, 153

corectopia 123

complete 102, 103

ciliopathies 149–50

cornea 17

congenital rubella 216

cimetidine, oral 253

birth trauma 88–9

diagnosis 108

ciprofloxacin 72

cystine crystals 194–5

etiology 104–7

Coats’ disease 132–4, 264

development 86

JIA-associated uveitis 156

‘cobblestone’ papillae 80, 81

edema 22, 153

lamellar 100, 101

cocaine solution 240

enlargement in glaucoma

management 108–11

collagen synthesis, disorders

117, 119

nuclear 100

202

keratic precipitates 153

persistent fetal vasculature

coloboma

scarring 117

144, 145

associated syndromes 169

structure/thickness 17

posterior polar 100

eyelid 186–7

trauma/abrasion 280–1

prognosis 112

lens 98

ulcer 70, 71, 80–1

subcapsular 102, 103

optic disc 169

corneal opacity

‘sunflower’ 200

color vision testing 30

congenital 86–90

sutural 102, 103

commotio retinae 284, 285

glaucoma 117, 118, 129

traumatic 284

cone-rod dystrophy 150

infectious disease 95–6

visual significance 108

congenital hereditary

metabolic disease 91–5

cats 158

endothelial dystrophy

corneal transplantation 87

cavernous hemangioma,

(CHED) 89, 118

cortical visual impairment 236

retina 232, 265

congenital hereditary stromal

corticosteroids

ceftriaxone 84

dystrophy (CHSD) 90

cataract formation 106, 107

cellulitis, orbit 191

congenital hypertrophy of

dacryoadenitis 184

central nervous system

retinal pigment epithelium

ophthalmic drops 72, 76,

(CNS) malformations 164,

(CHRPE) 270

82

166

congenital stationary night

Corynebacterium diptheriae 70

ceramide trihexosidase 201

blindness (CSNB) 136–7,

cover test 28–9, 53

chalazion 13, 190

170

alternate 29

CHARGE association 169

conjunctiva 18, 66

cranial nerve palsy

Chediak–Higashi syndrome

complex choristoma 233

fourth 16, 59–60

149, 210, 213

follicles 74, 75

sixth 60

chemical injuries 83–4, 281

injection 70, 74, 75

third 58–9

chemosis, conjunctival 79

tumors 244, 245, 249–58,

cranial nerves, eyelid function

chemotherapy 262–3, 263,

250

186

272

conjunctival intraepithelial

cross cover test 24, 25

child abuse 289

neoplasia (CIN) 253–4

cross-fixation 26

 

 

Index 315

 

 

 

Cryo-ROP Study 38

electro-oculogram (EOG)

flashlight test 23

cryotherapy 253, 256

142

fluorescein angiography 133,

cryptophthalmos 186

electroretinography (ERG)

227

cycloablation 130

134, 135, 138, 142, 147

fluorescein staining 281

cyclopentolate 49

embryology 86, 144

fluoroquinolones 72, 73

cystathionine beta synthase

endocrine abnormalities 166,

folinic acid 158

(CBS) deficiency 198

167

follicles, conjunctival 74, 75

cystinosis 94–5, 194–5

enhanced S-cone syndrome

forced duction testing 62,

cytokines, vasoactive 33–4, 42

136

192

 

enophthalmitis 159

forceps injury 117

dacryoadenitis 184

enophthalmos 286

foreign bodies

dacryocele 178–9

entropion 189

cornea 281

dacryocystitis 178

enzyme replacement therapy

eyelid 276, 277

dacryoplasty, balloon 181

204, 206, 207

intraocular 278, 279

dacryostenosis, congenital 69

eosinophilic granuloma 272

intraorbital 288

de Morsier’s syndrome 164

epiblepharon 189

forme fruste 218

dendrites, corneal 76

epicanthal folds 188

fornix 18, 66

dental anomalies 123

epiphora 116, 152, 180

fovea 20

dermoid cyst 271

erythromycin 72, 84

foveal hypoplasia 148

dermoid tumors 88, 251

esotropia 26, 64

Fuch’s coloboma (congenital

dermolipoma 251

accommodative 56–7

tilted disc) 170–1

Descemet’s membrane 17, 86

congenital 54, 54

fundus, hypopigmentation

deposits in Wilson’s disease

euryblepharon 188

210, 211

200

exotropia 57

galactosemia 104

rupture 119

extraocular muscles 14–17

snail track opacity 90

functions 15

α-galactosidase A 201

tears 88

eye

gamma aminobutyric acid

developing countries 259

defense mechanisms 69

(GABA) 45

diabetes mellitus 104, 166,

exposure 188

ganglion cells 19

167

structural diagram 67

gatifloxacin 72

dissociated vertical deviation

eye movements, binocular

gentamicin 72

(DVD) 55

29

germinal matrix 236

dog-bite trauma 276, 277

‘eye popping’ 189

giant papillary conjunctivitis

dorzolamide 128

eye shield 278, 279, 282

77

double elevator palsy

eyelashes

glands of Krause 13

(monocular elevation

matting 70

glands of Manz 13

deficiency) 62–3

pediculosis 189–90

glands of Wolfring 13

Down’s syndrome 104

eyelids 186

glasses, see spectacles

drusen 176

anatomy 12–13

glaucoma

Duane’s syndrome 61

coloboma 186–7

associated with ocular

ductions, testing 29–30, 62,

foreign bodies 276, 277

anomalies 123–5

192

herpes simplex 191

associated with systemic

dye disappearance test 180

retraction 188–9

disease 121

dysautonomia, familial

trauma 192, 276–7

congenital 22, 216

(Riley–Day syndrome)

tumors 190–1, 244, 245,

diagnosis 114–18

183

246–9

filtering procedures 77

dysostosis multiplex 204

Fabry’s disease 94, 104, 201

following cataract surgery

 

127

Early Treatment of

fascia bulbi (Tenon’s capsule)

juvenile open-angle 120

Retinopathy of Prematurity

66

neurofibromatosis 222

(ET-ROP) Study 36, 41

fibrillin 196

Peters anomaly 87

ecchymosis 276

fibrogliosis 232

primary 114–15, 119–20

ectopia lentis 98–9, 196, 197,

fine-needle aspiration biopsy

pupillary block 196

198, 199

(FNAB) 245

secondary 114–15, 126–7

ectropion 189

fixation testing 23, 26, 47

signs and symptoms 114,

eczema 80

flare, anterior chamber 154

115, 116, 180

316 Index

glaucoma (continued) Sturge–Weber syndrome

230

treatment 128–30 globe, open 278–9 globe retraction 61

glycosaminoglycans (GAGs) 91, 204, 205

goblet cells, conjunctival 66 Goldenhar syndrome 88, 169,

251 gonioscopy 157

goniotomy 120, 129, 130 gonococcal disease 83–4 Gorlin–Goltz syndrome 248 granulocytic sarcoma

(‘chloroma’) 272, 273 ‘gray line’ 66

Haab’s striae 119

Haemophilus influenzae 70, 72

Hallermann–Streiff syndrome 106

hamartoma

astrocytic retinal 218–20, 266, 267

iris (Lisch nodules) 122, 222, 223, 224

Harm’s trabeculotome 130 head nodding 239

head positions, anomalous (AHPs) 214

head thrusting 241 head tilt 59, 239 head turn 239

headache, migraine 237 hemangioblastoma 225, 226,

227 hemangioma

capillary 190, 231, 246–7, 257, 264

cavernous 232, 265 choroidal 230–1, 266 retinal 264–5

hemangiomatosis encephalofacial cavernous

(Sturge–Weber syndrome) 191, 230–1

racemose (Wyburn–Mason syndrome) 229, 265 hematoma, intraretinal 208–9 hemianopia, bitemporal 170

hemorrhage retinal 289 retrobulbar 288

subconjunctival 280

heparin sulfate 91 hereditary benign

intraepithelial dyskeratosis (HBID) 253

Hermansky–Pudlak syndrome 149, 210, 213, 215

herpes simplex virus (HSV) 76, 83, 83, 95, 157, 191

herpes zoster virus (HZV) 76, 157

heterochromia 255 heterophoria (phoria) 29, 52 heterotropia 28–9, 52 Hirschberg corneal reflex test

52–3

Hirschberg estimates 29 histamine release 78 history taking 22 HLA-B27 haplotype 126,

156 homatropine 49

homocystinuria 198–9 hordeolum 190 Horner–Trantas dots 80, 81 Horner’s syndrome 240–1 HOTV test 24, 26, 46 human papillomavirus 253 Hunter’s syndrome (MPS II)

92, 204, 206 Hurler’s syndrome

(MPS I-H) 92, 204, 205 Hutchinson’s triad 96 hyaloid artery 144 hydroxyamphetamine drops

240 hyperopia 56

hypersensitivity reactions 82 hyphema 126, 157, 282–3 hypoglycemia, cataracts 104 hypopituitarism 166, 167 hypopyon 154, 162 hypothyroidism 194 hypoxic ischemic injury 236

I-Cell disease (ML II) 93 immunosuppression 254 inferior oblique muscle over

action (IOOA) 55 insulin-like growth factor-1

(IGF-1) 34 interferon, topical 253

International Classification of Retinoblastoma (ICRB) 261–2, 261

intracranial pressure (ICP), raised 60, 174

intraepithelial neoplasia, conjunctival (CIN) 253–4

intraocular lens (IOL) 109–10, 111

Marfan’s syndrome 197 multifocal 111

traumatic cataract 284, 285 intraocular pressure (IOP)

elevation 114, 180 measurement 118 orbital injury 288

iridocorneal angle 18 iridocorneal endothelial

(ICE) syndrome 106 iridodenesis 196 iridodialysis 282, 283, 285 iris 18

atrophy 157, 199 congenital defects 123 Lisch nodules 122, 222,

223, 224 nodules 156, 157

scarring (synechiae) 154 transillumination 210, 211,

212–13

irrigation, ocular surface 281 Ishihara testing 30 isotretinoin 183

Joubert syndrome 149, 150 juvenile idiopathic arthritis

(JIA) 126, 155–6

juvenile pilocytic astrocytoma (optic nerve glioma) 224, 272, 273

Kaposi’s sarcoma 248 Kayser–Fleischer ring 200 keratic precipitates 153 keratitis 70, 71, 191 keratoconjunctivitis,

phlyctenular 82 keratopathy, band 156 Krimsky light reflex testing 53

lacerations conjunctiva 280 eyelid 276–7

lacrimal glands 13, 178 choristoma 252

lacrimal sac 14 fistula 182

lacrimal system 13–14 massage 179, 181

see also nasolacrimal duct lagophthalmos 188

 

 

Index 317

 

 

 

lamina cribosa 17–18

Marcus–Gunn jaw-winking

Moraxella catarrhalis 70

Langerhan’s cell histiocytosis

syndrome 187, 188

morning glory disc anomaly

272

Marfan’s syndrome 98, 99,

168

laser therapy 40, 130

196–7

Morquio’s syndrome (MPS

latanaprost 128

Maroteaux–Lamy syndrome

IV A and B) 93, 204, 207

Laurence–Moon syndrome

(MPS VI A and B) 93, 204,

moxifloxacin 72

150

207

mucolipidosis 93–4

Lea symbols 24, 26, 27, 46

masquerade syndromes 155,

mucopolysaccharidoses 91–4,

Leber’s congenital amaurosis

162

204–5, 206–7

(LCA) 134–5, 150

mast cells, degranulation 78

idiopathic 93

lens

maternal infections, cataract

Müller’s muscle 12, 186

anatomy and development

formation 107

myasthenia gravis 242

98

medications

Mycobacterium tuberculosis 82

dislocation/subluxation

causing cataracts 106–7

myelination, retinal nerve

(ectopia lentis) 98–9,

causing decreased tear

fibers 172–3

196, 197, 198, 199, 284

production 183

myopia 116

lenticonus 99, 104, 105

medicolegal issues, ROP 42

myotonic dystrophy 105

leukemia 162, 258, 270

medulloepithelioma,

 

leukocoria 23, 108, 244, 245

intraocular 266, 267

nasal fundus ectasia 170–1

levator palpebrae muscles

meibomian glands 13

nasolacrimal duct 14, 178

12–13, 186, 276

chalazion 13, 190

intubation 181–2

levofloxacin 72

melanocytic tumors,

obstruction 22, 178, 179,

lid retraction, pathologic

conjunctival 254–6, 254

180–2

188–9

melanocytoma, optic nerve

probing 179, 181

light reflex testing 29–30,

266, 267

Neisseria spp. 70, 83–4, 83

52–3

melanocytosis, ocular 254,

neural crest cells, migration

limbus 18

255

86

linear sebaceous nevus

melanoma 254, 255, 256, 258

neurilemoma (schwannoma)

syndrome 169

uveal 268, 268, 269

249

lipofuscin 140

meningoencephalocele 178

neuroblastoma 239, 273

Lisch nodules 122, 222, 223,

metabolic diseases 91–5

neurofibroma 222, 248, 249

268

cataracts 104–5

neurofibromatosis 122, 191,

Lowe’s syndrome 104, 121

cystinosis 94–5, 194–5

222–5, 223, 248, 249

lymphadenopathy,

Fabry’s disease 94, 104,

neuroma, plexiform 191

conjunctivitis 70

201

nevi

lymphangioma 272

homocystinuria 198–9

conjunctival 255–6

conjunctiva 257

mucopolysaccharidoses

eyelid 190, 191

eyelid 191

91–4, 204–5, 206–7

melanocytic 248

lymphoid tumors 258

tyrosinemia 95

pigmented 254, 255–6

lysosomal storage disease

methionine levels 198

uveal 268

105

methylene tetrahydrofolate

nevus flammeus (port-wine

macrolide antibiotics 72

reductase (MTHFR)

stain) 191, 231, 248, 249,

deficiency 198

266

macula 20

microcornea 216

nevus sebaceous of Jadassohn

‘egg-yolk’(vitelliform) 142,

microphthalmia 186, 216

233, 252

143

microspherophagia 197

night blindness, congenital

granuloma in toxocariasis

microspherophakia 99

stationary 136–7, 170

159

MIDAS syndrome 87

nystagmus 108, 170, 210,

puckering in VKH 160,

migraine headache 237

215, 238, 239

161

mitomycin C 253, 256

 

retinoblastoma 262, 263

Mittendorf’s dot 144

occlusion

scarring in toxoplasmosis

Möbius syndrome 64

amblyopia therapy 48

158–9

molluscum contagiosum

strabismus testing 28, 29

uveitic swelling 152, 153

191–2

visual acuity testing 26, 27

macular degeneration 150

monocular elevation

ocular alignment, testing 24,

mannosidosis 105

deficiency (MED) 62–3

25

318 Index

 

 

 

ocular examination 22–3

organoid nevus syndrome

port-wine stain (nevus

glaucoma 117–18

233, 234, 252

flammeus) 191, 231, 248,

ocular flutter 239

orthophorhia 52

249, 266

ocular motor apraxia,

osseous choristoma, epibulbar

posterior polymorphous

congenital 241

252

membrane dystrophy

oculocerebrorenal syndrome

osteogenesis imperfecta

(PPMD) 90

(Lowe’s syndrome) 104,

202–3

posterior segment 19–20

121

osteoma, choroidal 266, 267

posterior synechiae 154

oculoneurocutaneous

otitis media, acute 71

primary acquired melanosis

syndromes (ONCS) 218

oxygen administration,

(PAM) 254, 256

genetics 218

neonatal 33–4, 42

primary ciliary dyskinesia 150

malignant potential 218

 

proptosis 271, 272, 273

TSC 218–21

PanOptic ophthalmoscope 31

prostaglandin analogs 128

ofloxacin 72

panuveitis 160, 161

pseudo-Hurler dystrophy

open globe 278–9

papillae, tarsal conjunctivae

(ML III) 94

ophthalmia neonatorum

80, 81

pseudohypopyon 162

83–4, 83

papilledema 174

pseudomembrane 70, 71

ophthalmoscopy 31

papilloma 253

Pseudomonas infections 70, 71,

direct 23, 24, 25, 31, 117

parasites, gastrointestinal 82

83, 280

indirect 132

parents 22

pseudopapilledema 175

opsoclonus 239

pars plana 19

pseudophakia 111

optic canal, decompression

pars plicata 18–19

pseudoptosis 62, 63

286

patching 48, 110, 111

pseudostrabismus

optic disc

Paton’s lines 174

(pseudoesotropia) 53

coloboma 169

pattern-evoked potential

pseudotumor cerebri 174,

congenital tilted 170–1

(PEVP) 32

209

cupping 116

pediculosis, eyelashes 189–90

psychosocial factors 43

drusen 176

penalization 49

ptosis

morning glory anomaly

D-penicillamine 41

3rd cranial nerve palsy 58,

168

perennial allergic

59

optic nerve

conjunctivitis (PAC) 78, 79

congenital 13, 187–8

hypoplasia 164–7

periventricular leukomalacia

myasthenia gravis 242

melanocytoma 266, 267

166

upper and lower lids 240

pilocytic astrocytoma

persistent fetal vasculature

pulleys 15

(glioma) 224, 272, 273

(PFV) 99, 144–5, 264

puncta 13, 178

retinoblastoma 259

Peters anomaly 86–7, 106,

pupil 18

trauma 286

125

pupillary axis 29

optic neuropathy

‘phakomatoses’ 218

pupillary constriction 240–1

clinical principles 164

phlyctenulosis 82

pupillary defects, afferent 23

unilateral 164

‘photic sneeze reflex’ 195

pupillary dilation 23

optic pit 172, 173

photocoagulation 40

pupillary reflex

optic radiations 236

photophobia 116, 117, 129,

unequal 44

optical axis 29

195

white (leukocoria) 23, 108,

optical coherence

photoscreening 32

244, 245

tomography (OCT) 210,

phthisis 281

pupillary strands 144

245

pineal cysts 260

pyogenic granuloma 257

ora serrata 19

pinealoblastoma 259–60

 

orbicularis oculi muscle 12,

pink eye, see conjunctivitis

racial melanosis 254, 256

186

pituitary abnormalities 166,

radiotherapy 258, 263–4,

orbit

167

263

anatomy 12

plaque radiotherapy 263–4

Random-dot-E test 24, 25, 31

cellulitis 191

plexiform neuroma 191

rectus muscles 14, 15, 16–17

septum 13

Plus disease 36–7

red eye, see conjunctivitis

trauma 12, 192, 286–8

polycoria 123

red reflex 23, 24, 25, 108

tumors 222, 244, 245, 246,

polymixin B/trimethoprim

Refsum disease 105, 150

271–3

sulfate 72

renal disease 194, 201

 

 

Index 319

 

 

 

retina

retinopathy of prematurity

skin macules, depigmented

astrocytic hamartoma

(ROP) 33

220, 221

218–20, 266, 267

clinical presentation 35–8

Sly’s syndrome (MPS VII) 93,

cavernous hemangioma

diagnosis 38

204, 207

232, 265

etiology/risk factors 33–4

small leucine-rich

hemangioblastoma 225,

management/prognosis

proteoglycan (SLRP) 136

226

38–41

sneezing, photic 195

normal human 20

pathophysiology 34–5

Snellen charts 24, 26, 46

racemose hemangioma 229,

prevention 41–2

socioeconomic factors 43

265

retinoschisis

spasmus nutans 239

structure 19–20

traumatic 289

spectacles

telangiectasia 132

X-linked juvenile 146–7

accommodative esotropia

traumatic injury 284–5

retrobulbar hemorrhage 288

56

retinal blood vessels

rhabdomyosarcoma 272, 273

aphakic 110, 111

excessive oxygen exposure

Richner Hanhart syndrome

spherophakia

33–4

(tyrosinemia type II) 95

(microspherophakia) 99

tortuous 201, 265

Riley–Day syndrome 183

spiral of Tillaux 14, 15

retinal detachment 20

rod monochromatism 138

spondyloarthropathies,

Marfan’s syndrome 197

Rose Bengal staining 76

juvenile 156–7

in ROP 40–1

Rothmund–Thomson

squamous cell carcinoma

sickle cell disease 209

syndrome 190

253–4

toxocariasis 159

rubella 96, 107, 216

squamous papilloma 253

trauma 284, 285

Rush disease 36–7

Staphylococcus aureus 70, 73,

VKH syndrome 161

‘salmon patch’ 258

82

retinal dystrophies 149–50

staphyloma

retinal nerve fibers,

salmon patch hemorrhage

anterior 199

myelinated 172–3

208–9

peripapillary 170, 171

retinal pigment epithelium

Sanfilippo A syndrome 204,

Stargardt disease 140–1

19, 20

206

stereo Fly (Titmus) test 30–1

congenital hypertrophy

sarcoidosis 156, 157

stereoacuity, assessment 30–1

(CHRPE) 270

Scheie’s syndrome (MPS I)

strabismus

retinitis pigmentosa (RP)

92, 204, 206

albinism 214–15

149, 150

Schwalbe’s line 18

amblyopic 44

retinoblastoma 126, 162,

schwannoma 222, 223, 249

comitant (esodeviations)

259–64

sclera 17

52, 54–7

classification 261–2,

blue 202, 203

definitions 52

261

hydration 17

diagnosis 28–30, 52–3

clinical presentation 162,

trauma 278

incomitant 52, 58–60

244, 245

sclerocornea 87

infancy 53

diagnosis and management

scopolamine (hyoscine) 49

ocular tumors 245

162, 246, 261–4

scotoma 158–9

surgery 55, 60

disorders resembling

scintillating 237

strabismus syndromes 61–4

264

seasonal allergic conjunctivitis

Streptococcus pneumoniae 70,

genetic mutations/testing

(SAC) 78, 79

72

259

seborrheic blepharitis 189

Sturge–Weber syndrome 121,

metastasis 259

Senior–Loken syndrome 150

191, 230–1, 248, 249, 266

second cancers 260–1

septo-optic dysplasia (de

subconjunctival hemorrhage

‘trilateral’ 259–60

Morsier’s syndrome) 164

280

retinocerebellar

Seton implant 130

subretinal hemorrhage 285

hemangioblastomatosis

shaking injury 289

substantia propria 66

(von-Hippel–Lindau

shield ulcer 80–1

sulfacetamide sodium 72

syndrome) 226–8

sialidosis (ML I) 93

sulfisoxazole 72

retinochoroiditis,

sickle cell disease 208–9, 282

sulfonamides 72

toxoplasmosis 159

sickle cell trait 209

suprasellar tumors 170

retinopathy, ‘salt and pepper’

silver nitrate 83–4

sympathetic ophthalmia

216

Sjögren’s syndrome 183

160–1

320 Index

 

 

 

synechiae, posterior/anterior

trauma (continued)

visual behavior assessment 47,

154

sympathetic ophthalmia

108

syphilis, congenital 96

160–1

visual deprivation 45

systemic disease

travoprost 128

visual development 43–4, 111

associated with ptosis 187

tuberous sclerosis complex

visual evoked potential 32

glaucoma associated with

(TSC) 218–21

visual experience, abnormal

121

tumbling E test 24

45

retinal dystrophies 149–50

tumors

visual field deficits 170, 171,

see also metabolic disease

causing glaucoma 126

174, 195

and individual diseases

conjunctival 249–58

visual pathway abnormalities

 

diagnostic approaches

210, 214

tarsal plates 186

245–6

vitamin A 41, 150

tarsorrhaphy 183

eyelids 190–1, 244, 245,

vitamin E 41

tarsus 12

246–9

vitelliform macular dystrophy

tearing, see epiphora

intracranial 58

type 2 (VMD2/Best’s

tears 13

intraocular 244

disease) 142–3

constituents 66

metastatic 259, 273

vitiligo 160, 161

decreased production 183

non-neoplastic lesions

vitrectomy 41, 109–10

drainage 13–14

simulating 250, 258

vitreous 144

telemedicine 41

orbit 222, 244, 245, 246,

vitreous hemorrhage 289

Tenon’s capsule (fascia bulbi)

271–3

Vogt–Koyanagi–Harada

66

tyrosinase 148

syndrome 160, 161

teratoma 271

tyrosinemia 95

von Recklinghausen’s

thermotherapy 263

 

syndrome, see

‘three step test’ 59

Usher syndrome 149

neurofibromatosis

thymectomy 242

uvea 18–19, 152

von-Hippel–Lindau syndrome

thyrotoxicosis 188

uveitis 152

(VHL) 226–8, 264

Titmus (stereo Fly) test

anterior 126, 155–7, 155

 

30–1

classification 154, 155

Walker–Warburg syndrome

tobramycin 72

clinical features 152–4

169

Togby’s (corneal shield)

glaucoma 126–7

wart, eyelid 192

ulcers 80–1

intermediate 155, 158

Welch Allyn SureSight™ 32

Tonopen 118

masquerade syndromes

Wilm’s tumor 106

TORCHS titer 108

155, 162

Wilson’s disease 105, 200

torticollis 214, 239

posterior 155, 158–61

Wyburn–Mason syndrome

toxicities, cataract formation

 

229, 265

107

valve of Hasner 14, 178, 179,

 

toxocariasis 159

181

xanthogranuloma, juvenile

toxoplasmosis 158–9

valve of Rosenbuller 14

257

trabeculectomy 130

vascular endothelial growth

xeroderma pigmentosum 190

trabeculitis 127

factor (VEGF) 33–4

 

trabeculotomy 120, 129–30

inhibitors 42

 

trachoma inclusion

Venereal Disease Research

 

conjunctivitis agent (TRIC)

Laboratory (VDRL) 108

 

84

vernal keratoconjunctivitis

 

Trantas 80, 81

(VKC) 77, 80–1

 

trauma

verruca vulgaris 192

 

causing cataracts 1–3, 102,

versions 29

 

106, 107, 284

verticilatta, corneal 94,

 

eyelid 192, 276–7

201

 

glaucoma 126

vestibulo-oculoreflex 241

 

intraocular 282–3

vision screening 31

 

ocular surface 280–1

visual acuity testing 23–7

 

optic nerve 286

amblyopia 46, 47–8

 

orbit 12, 192, 286–8

guidelines 23, 24–5

 

retina 284–5

visual axis 29